Irbesartan Stada (Irbesartan)

Irbesartan works by selectively blocking angiotensin II type 1 (AT1) receptors. This prevents angiotensin II from causing blood vessels to narrow and from stimulating aldosterone release, resulting in vasodilation, reduced sodium and water retention, and lower blood pressure, while also lessening pressure within the kidney’s filtering units.

The dose of Irbesartan Stada is individualized by the prescribing healthcare professional based on the patient’s blood pressure, kidney function, and overall clinical condition. The prescriber will determine the appropriate strength and frequency according to current treatment guidelines.

Irbesartan is classified as pregnancy Category D, indicating evidence of fetal risk and it is contraindicated during pregnancy. Limited data are available for breastfeeding; therefore, use is generally discouraged unless the potential benefit outweighs the risk. Women of child‑bearing potential should use effective contraception.

To order Irbesartan Stada, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and the necessary import documentation.

Irbesartan belongs to the ARB class, which offers blood‑pressure control comparable to ACE inhibitors but with a lower incidence of cough and angio‑edema. Unlike some diuretics, it does not cause electrolyte loss, and it provides additional renal protection in diabetic patients, making it a preferred option for those with kidney concerns.

Irbesartan Stada should be stored at room temperature, below 25 °C. Keep the tablets in the original packaging, protect them from moisture, heat, and direct sunlight to maintain stability and potency throughout the shelf life.

Irbesartan Stada is taken orally, usually as a whole tablet with or without food. Patients should swallow the tablet with a full glass of water and follow the dosing schedule prescribed by their healthcare provider.

The most serious risks include angio‑edema (swelling of the face, lips, tongue, or throat), severe hyperkalemia (elevated potassium levels), and acute renal failure or worsening kidney function. Patients should seek immediate medical attention if they experience swelling, difficulty breathing, or sudden changes in kidney‑related lab values.

Irbesartan Stada should not be used by individuals who are pregnant, have known hypersensitivity to Irbesartan or any ARB component, or have severe hepatic impairment. Caution is also advised for patients with existing renal dysfunction, high potassium levels, or those taking interacting medications such as aliskiren in diabetes.